Nomura Holdings
OLMA icon

Nomura Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Nomura Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$826K Buy
66,000
+27,500
+71% +$368K ﹤0.01% 1412
2026
Q1 		$574K Hold
38,500
– – ﹤0.01% 1320
2025
Q4 		$963K Buy
+38,500
New +$685K ﹤0.01% 1350

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Nomura Holdings's OLMA Position: Q2 2026 in Review

Nomura Holdings reduced its Olema Pharmaceuticals (OLMA) stake by 19% in Q2 2026, selling an estimated $109K and leaving 33,856 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Nomura Holdings first reported a position in OLMA in Q4 2021 and has held it in 3 quarters since. The position peaked at $626K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Nomura Holdings held 33,856 shares of Olema Pharmaceuticals worth $424K as of Q2 2026.
  • Nomura Holdings sold 8,104 Olema Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Olema Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1551 holding.
  • Nomura Holdings first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 3 quarters since.
  • Nomura Holdings's Olema Pharmaceuticals position peaked at $626K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.